Related Experiment Video

Updated: Apr 6, 2026

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

7.1K

Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current

Sami Hraiech1, Fabienne Brégeon2, Jean-Marc Rolain3

  • 1Institut Hospitalo-Universitaire Méditerranée Infection, URMITE CNRS IRD INSERM UMR 7278, Marseille, France ; Réanimation Médicale - Détresses Respiratoires et Infections Sévères, APHM, CHU Nord, Marseille, France.

Drug Design, Development and Therapy
|July 28, 2015
PubMed

Insights

Bacteriophage therapy shows promise for treating Pseudomonas aeruginosa lung infections in cystic fibrosis (CF) patients, addressing the challenge of multidrug-resistant bacteria. Further clinical trials are needed to confirm efficacy in CF pneumonia.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pseudomonas aeruginosa lung infections significantly worsen respiratory status in cystic fibrosis (CF) patients.
  • Multidrug-resistant strains are emerging due to repeated antibiotic treatments, necessitating novel therapeutic strategies.
  • Bacteriophage therapy, with a history of use in ex-USSR countries, is gaining renewed interest for bacterial infections.

Purpose of the Study:

  • To review the evidence for bacteriophage efficacy against Pseudomonas aeruginosa.
  • To specifically examine in vitro studies, animal models, and clinical trials relevant to CF patients.
  • To assess the potential of bacteriophage-based therapy for pulmonary infections in CF.

Main Methods:

  • Literature review of existing studies on bacteriophage efficacy.
  • Analysis of in vitro data on bacteriophages targeting Pseudomonas aeruginosa.
  • Examination of animal models and available clinical trial data, particularly in the context of CF.

Main Results:

  • In vitro data suggest bacteriophage therapy holds significant potential for treating pulmonary infections in CF patients.
  • While clinical data in CF patients are limited, emerging studies in other infections indicate therapeutic promise.
  • Bacteriophages are effective against a broad spectrum of bacterial infections, including Pseudomonas aeruginosa.

Conclusions:

  • Bacteriophage therapy represents a promising alternative for managing Pseudomonas aeruginosa infections in CF.
  • The review highlights the need for more extensive clinical trials to validate bacteriophage efficacy in CF pulmonary infections.
  • Assessing bacteriophage effectiveness against Pseudomonas aeruginosa in CF patients is timely given the rise of antibiotic resistance.
Keywords:
bacterial infectionmultidrug resistancepneumoniapulmonary infection

More Related Videos

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

34.3K
Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

3.7K

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
80.2K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
626
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
895
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.5K